Home > Healthcare > Autotransfusion Devices Market

Autotransfusion Devices Market Trends

Report ID: GMI8266
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Autotransfusion Devices Market Trends

The market is experiencing several notable trends that are shaping its growth and development. Factors such as continuous technological advancements in autotransfusion devices, growing trend towards miniaturization and portability, and a surging demand for integrated imaging and surgical navigation systems, among other factors are propelling the industry growth.

Further, there is a growing trend towards miniaturization and portability of autotransfusion devices, enabling their use in various clinical settings, including operating rooms, emergency departments, and critical care units. Compact and portable autotransfusion systems offer flexibility, convenience, and rapid deployment for intraoperative blood salvage and transfusion.
Moreover, integration of autotransfusion devices with surgical navigation and imaging systems enhances intraoperative visualization, precision, and safety during complex surgical procedures. Seamless integration allows surgeons to monitor blood quality, optimize transfusion parameters, and adjust treatment strategies in real time, improving patient outcomes and surgical efficiency.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The autotransfusion devices industry was valued at around USD 514.6 million in 2023 and is estimated to reach over USD 910.1 million by 2032, attributed to ongoing advancements in technology, surging need for point-of-care testing (POCT) technologies, increasing demand for complex surgical procedures and minimally invasive techniques.

The autotransfusion systems segment garnered USD 394.6 million in 2023 and will grow through 2032 as they reduce the risks associated with allogeneic blood transfusions, such as transfusion responses, infectious disease transfer, and immune-mediated problems.

North America autotransfusion devices industry accounted for USD 211.7 million in 2023 and is predicted to witness substantial growth through 2032 as the region has a highly sophisticated healthcare infrastructure, which includes cutting-edge medical facilities, technologically advanced equipment, and a well-established network of hospitals, surgery centers, and specialist clinics.

Atrium Medical Corporation, Becton, Dickinson and Company, Beijing ZKSK Technology Co., Ltd., Braile Biomédica, Fresenius SE & Co. KGaA, Gen World Medical Devices, Haemonetics Corporation, LivaNova, Inc., Medtronic plc, Redax, and Teleflex Incorporated.